Latest News

  • Illumina Gets Companion Diagnostic Indication in EU for Pan-Cancer Test

    Diagnostics World | This week Illumina announced the addition of a companion diagnostic (CDx) indication to its CE-marked in vitro diagnostic TruSight Oncology (TSO) Comprehensive (EU) test. This single test kit, recently launched across Europe, assesses multiple tumor genes and biomarkers to reveal the specific molecular profile of a patient's cancer.

    May 27, 2022
  • $10M Lyme Disease Dx Prize, Ultrarapid WGS from PerkinElmer, More

    Diagnostics World News | An AI-based diagnostic histoculture platform preserves human tumor microenvironment; FUJIFILM partners with over 150 imaging centers across the United States; two multiplex respiratory virus tests enable rapid differentiation and detection; and more.

    May 26, 2022
  • Follow the Money: Parkinson’s Screening, Lung Disease Early Detection, More

    Diagnostics World News| Funding for pathology diagnostics, rapid DNA sequencing, AI-powered disease detection, and more.

    May 25, 2022
  • Point-Of-Care Skin Cancer Imaging Device Moving Into Large-Scale Clinical Trials

    Diagnostics World News | Electrical and computer engineers at Stevens Institute of Technology, together with clinical dermatology specialists at Hackensack University Medical Center (HUMC), are collaboratively developing a low-cost, handheld imaging device that provides laboratory-grade diagnoses of different types of skin cancer. It should be received as a welcome alternative to skin biopsies, about half of which are unnecessarily done for want of another method for differentiating benign from cancerous tissue.

    May 19, 2022